Korro Bio KRRO
NASDAQ KRRO
$13.09 +0.13 (+1.00%)
As of: Aug 21, 2026 · 10:32 AM EDT

Korro Bio (KRRO) EBT Margin (QoQ) (2019 - 2025)

Korro Bio (KRRO) EBT Margin (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.00 Bn 132.14 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn
3 Argenx Se 65.24 Bn 60.06 Bn 1.37 Bn
4 Moderna 62.41 Bn 57.27 Bn 52.00 Mn
5 BeOne Medicines 42.25 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.18 Bn 27.88 Bn 992.69 Mn
7 BioNTech SE 28.93 Bn 10.54 Bn 668.28 Mn
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
9 Royalty Pharma 27.28 Bn 26.44 Bn -
10 Korro Bio 237.41 Mn 122.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 695,186.00
Sep 30, 2025 10,803.00
Jun 30, 2025 -84,786.00
Mar 31, 2025 -366,500.00
Jun 30, 2021 25,069.00
Mar 31, 2021 -33,499.00
Dec 31, 2020 -5,573.00
Sep 30, 2020 2,325.00
Jun 30, 2020 -350.00
Mar 31, 2020 4,954.00
Dec 31, 2019 -11,428.00